• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后肝窦阻塞综合征的超声精细化标准。

Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.

机构信息

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, N14 W5, Kita-ku, Sapporo, 060-8648, Japan.

Diagnostic Center for Sonography, Hokkaido University Hospital, Sapporo, Japan.

出版信息

Int J Hematol. 2021 Jul;114(1):94-101. doi: 10.1007/s12185-021-03137-3. Epub 2021 Mar 24.

DOI:10.1007/s12185-021-03137-3
PMID:33763826
Abstract

Hepatic sinusoidal obstruction syndrome (SOS)/veno-occlusive disease is a life-threatening complication after hematopoietic stem cell transplantation (HSCT). We previously reported the efficacy of the Hokkaido Ultrasonography (US)-based scoring system (HokUS-10) for US findings. To establish easier-to-use criteria, we retrospectively evaluated US findings from 441 patients, including 30 patients with SOS using the HokUS-10 scoring system. Using logistic regression analysis, we established the novel diagnostic criteria HokUS-6. In the presence of ascites, US diagnosis was made in the presence of two of the following 6 parameters: moderate amount of ascites, the appearance of a paraumbilical vein blood flow signal, gallbladder wall thickening, portal vein dilatation, portal vein velocity decrease, and hepatic artery resistive index increase. The AUC, sensitivity, and specificity of HokUS-6 were 0.974 (95% confidence interval 0.962-0.990), 95.2%, and 96.9%, respectively. The scores were significantly higher in patients with severe SOS than in those with non-severe SOS (p = 0.013). Furthermore, the scores before HSCT were significantly higher in patients who developed SOS than in controls (p = 0.001). The HokUS-6 is an easy and useful way to diagnose and identify the risk of SOS.

摘要

肝窦阻塞综合征(SOS)/静脉阻塞性疾病是造血干细胞移植(HSCT)后一种危及生命的并发症。我们之前报道了北海道超声(US)评分系统(HokUS-10)对 US 表现的疗效。为了建立更易于使用的标准,我们回顾性评估了 441 名患者的 US 表现,包括 30 名 SOS 患者,使用 HokUS-10 评分系统。使用逻辑回归分析,我们建立了新的诊断标准 HokUS-6。在腹水存在的情况下,US 诊断为以下 6 个参数中的两个:中等量腹水、脐旁静脉血流信号出现、胆囊壁增厚、门静脉扩张、门静脉速度降低和肝动脉阻力指数增加。HokUS-6 的 AUC、敏感性和特异性分别为 0.974(95%置信区间 0.962-0.990)、95.2%和 96.9%。严重 SOS 患者的评分明显高于非严重 SOS 患者(p=0.013)。此外,发生 SOS 的患者 HSCT 前的评分明显高于对照组(p=0.001)。HokUS-6 是一种简单而有用的方法,可用于诊断和识别 SOS 的风险。

相似文献

1
Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.造血干细胞移植后肝窦阻塞综合征的超声精细化标准。
Int J Hematol. 2021 Jul;114(1):94-101. doi: 10.1007/s12185-021-03137-3. Epub 2021 Mar 24.
2
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.新型造血干细胞移植后肝窦阻塞综合征超声评分系统。
Biol Blood Marrow Transplant. 2018 Sep;24(9):1896-1900. doi: 10.1016/j.bbmt.2018.05.025. Epub 2018 May 24.
3
Reliability of an ultrasonographical scoring system for diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.用于诊断造血干细胞移植患者窦状隙阻塞综合征/静脉阻塞病的超声评分系统的可靠性。
J Med Ultrason (2001). 2021 Jan;48(1):45-52. doi: 10.1007/s10396-020-01071-1. Epub 2021 Jan 4.
4
HokUS-10 scoring system predicts the treatment outcome for sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.HokUS-10 评分系统预测异基因造血干细胞移植后窦状隙阻塞综合征的治疗结果。
Sci Rep. 2023 Oct 13;13(1):17374. doi: 10.1038/s41598-023-43806-3.
5
Assessment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome using different scanning approaches for the ultrasonographic evaluation of portal vein blood flow and hepatic artery resistive index in hematopoietic stem cell transplant recipients.采用不同的超声扫描方法评估造血干细胞移植受者门静脉血流和肝动脉阻力指数对肝静脉闭塞病/窦阻塞综合征的评估。
J Med Ultrason (2001). 2023 Oct;50(4):465-471. doi: 10.1007/s10396-023-01335-6. Epub 2023 Jul 4.
6
Grayscale and Spectral Doppler Ultrasound in the Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children.灰阶及频谱多普勒超声在儿童造血干细胞移植后肝静脉闭塞病/窦性阻塞综合征诊断中的应用
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1105-e1110. doi: 10.1097/MPH.0000000000002334.
7
Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.胆囊壁水肿和腹水是造血干细胞移植儿童进展为肝静脉闭塞病的独立预测因子。
Eur Radiol. 2018 Jun;28(6):2291-2298. doi: 10.1007/s00330-017-5137-9. Epub 2018 Jan 2.
8
Spectral Doppler Ultrasound Can Help Diagnose Children With Hepatic Sinusoidal Obstructive Syndrome After Hematopoietic Stem Cell Transplantation.频谱多普勒超声有助于诊断造血干细胞移植后发生肝窦阻塞综合征的儿童。
Ultrasound Q. 2020 Mar;36(1):6-14. doi: 10.1097/RUQ.0000000000000441.
9
Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.肝硬度测量在造血干细胞移植后窦状隙阻塞综合征/静脉阻塞病诊断中的应用。
J Med Ultrason (2001). 2024 Apr;51(2):311-321. doi: 10.1007/s10396-023-01392-x. Epub 2023 Dec 19.
10
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.肝脏硬度测量可早期诊断造血干细胞移植成年患者的静脉闭塞病/窦状隙阻塞综合征:一项单中心前瞻性研究结果。
Biol Blood Marrow Transplant. 2019 May;25(5):995-1003. doi: 10.1016/j.bbmt.2019.01.019. Epub 2019 Jan 18.

引用本文的文献

1
Ultrasonographic scoring system for SOS/VOD in pediatric hematopoietic stem cell transplant recipients.儿童造血干细胞移植受者中SOS/VOD的超声评分系统
Int J Hematol. 2025 Apr 26. doi: 10.1007/s12185-025-03995-1.
2
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial.ELASTOVOD研究:造血干细胞移植(HSCT)后肝硬度测量对诊断肝静脉闭塞病/窦性阻塞综合征的诊断准确性,一项研究者发起的前瞻性多中心诊断性临床试验。
Bone Marrow Transplant. 2025 Apr 19. doi: 10.1038/s41409-025-02570-w.
3

本文引用的文献

1
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.新型造血干细胞移植后肝窦阻塞综合征超声评分系统。
Biol Blood Marrow Transplant. 2018 Sep;24(9):1896-1900. doi: 10.1016/j.bbmt.2018.05.025. Epub 2018 May 24.
2
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.一项关于去纤维肽治疗肝静脉闭塞病/窦状隙阻塞综合征患者的 IND 研究的最终结果。
Br J Haematol. 2018 Jun;181(6):816-827. doi: 10.1111/bjh.15267. Epub 2018 May 16.
3
Information criteria for Firth's penalized partial likelihood approach in Cox regression models.
Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations.
静脉闭塞性疾病的操作程序共享路径:基于德尔菲共识的建议
Front Oncol. 2025 Mar 12;15:1498782. doi: 10.3389/fonc.2025.1498782. eCollection 2025.
4
Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.改良 EBMT 诊断和严重程度标准 2023 年在窦状隙阻塞综合征/静脉阻塞性疾病中的应用。
Bone Marrow Transplant. 2024 Apr;59(4):518-525. doi: 10.1038/s41409-024-02215-4. Epub 2024 Jan 29.
5
Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.肝硬度测量在造血干细胞移植后窦状隙阻塞综合征/静脉阻塞病诊断中的应用。
J Med Ultrason (2001). 2024 Apr;51(2):311-321. doi: 10.1007/s10396-023-01392-x. Epub 2023 Dec 19.
6
Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia.造血干细胞移植后窦性阻塞综合征的早期诊断,采用包括难治性血小板减少症在内的改良诊断标准。
EJHaem. 2023 Jun 1;4(3):695-704. doi: 10.1002/jha2.728. eCollection 2023 Aug.
7
Assessment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome using different scanning approaches for the ultrasonographic evaluation of portal vein blood flow and hepatic artery resistive index in hematopoietic stem cell transplant recipients.采用不同的超声扫描方法评估造血干细胞移植受者门静脉血流和肝动脉阻力指数对肝静脉闭塞病/窦阻塞综合征的评估。
J Med Ultrason (2001). 2023 Oct;50(4):465-471. doi: 10.1007/s10396-023-01335-6. Epub 2023 Jul 4.
8
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.低血浆透明质酸水平可能排除造血干细胞移植后发生窦状隙阻塞综合征。
Dis Markers. 2023 Apr 17;2023:7589017. doi: 10.1155/2023/7589017. eCollection 2023.
9
Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.造血干细胞移植后迟发性窦性阻塞综合征/静脉闭塞性疾病的超声评分系统
Bone Marrow Transplant. 2022 Aug;57(8):1338-1340. doi: 10.1038/s41409-022-01717-3. Epub 2022 May 25.
Cox回归模型中Firth惩罚偏似然方法的信息准则
Stat Med. 2017 Sep 20;36(21):3422-3436. doi: 10.1002/sim.7368. Epub 2017 Jun 12.
4
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.成人患者窦性阻塞综合征/静脉闭塞性疾病的修订诊断和严重程度标准:欧洲血液和骨髓移植学会的新分类
Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16.
5
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.异基因造血干细胞移植后的窦性阻塞综合征:发病率、危险因素及预后
Bone Marrow Transplant. 2016 Mar;51(3):403-9. doi: 10.1038/bmt.2015.283. Epub 2015 Nov 23.
6
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).窦性阻塞综合征/静脉闭塞性疾病:现状与展望——欧洲血液与骨髓移植学会(EBMT)的立场声明
Bone Marrow Transplant. 2015 Jun;50(6):781-9. doi: 10.1038/bmt.2015.52. Epub 2015 Mar 23.
7
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.透明报告个体预后或诊断的多变量预测模型(TRIPOD):解释和说明。
Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.
8
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies.造血干细胞移植后肝静脉闭塞病:预防与治疗的争议
World J Transplant. 2012 Apr 24;2(2):27-34. doi: 10.5500/wjt.v2.i2.27.
9
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.清髓性治疗及骨髓移植后肝静脉闭塞病:100例患者中灰阶及多普勒超声的价值
Radiology. 1997 Aug;204(2):545-52. doi: 10.1148/radiology.204.2.9240551.
10
Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.骨髓移植后肝静脉闭塞病与多器官功能衰竭:一项对355例患者的队列研究
Ann Intern Med. 1993 Feb 15;118(4):255-67. doi: 10.7326/0003-4819-118-4-199302150-00003.